Abstract
We have determined drug/metabolite concentrations and ratios of methadone (METH) to two of its metabolites (EDDP, 2-ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidine; and EMDP, 2-ethyl-5-methyl-3,3-diphenylpyrroline) in postmortem peripheral blood and liver tissue by liquid chromatography/tandem mass spectrometry. The assays employed deuterated internal standards and multiple reaction monitoring (MRM) techniques. The assay linear range was 0.01–2.0 mg/l for each analyte. METH, EDDP, and EMDP were determined in liver and peripheral blood from 46 methadone-positive cases. METH and EDDP were detected in all specimens, whether blood or liver. EMDP was detected, only in liver, and only 17 cases, at concentrations much lower than those of EDDP. Concentrations of METH and EDDP in blood and liver from EMDP-positive cases were in ranges higher than, but overlapping with, concentrations in blood and liver from EMDP-negative cases. These data suggest that although METH is readily demethylated and cyclized to EDDP, in vivo, conversion to EMDP may be less efficient and its accumulation in postmortem tissues may be highly individual.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Karch SB, Stephens BG. Toxicology and pathology of deaths related to methadone: retrospective review. West J Med. 2000;172:11–4.
Milroy CM, Forrest ARW. Methadone deaths: a toxicological analysis. J Clin Pathol. 2000;53:277–81.
Gagajewski A, Apple FS. Methadone-related deaths in Hennepin County, Minnesota: 1992–2002. J Forensic Sci. 2003;48:668–71.
Wolf BC, Lavezzi WA, Sullivan LM, Flannagan LM. Methadone-related deaths in Palm Beach County. J Forensic Sci. 2004;49:375–8.
Beckett AH, Taylor JF, Casy AF, Hasson MA. The biotransformation of methadone in man. Synthesis and identification of a metabolite. J Pharm Pharmacol. 1968;20:754–62.
Pohland A, Boaz HE, Sullivan HR. Synthesis and identification of metabolites resulting from the biotransformation of dl-methadone in man and the rat. J Med Chem. 1971;14:194–7.
Alburges ME, Huang W, Foltz RL, Moody DE. Determination of methadone and its N-demethylation metabolites in biological specimens by GC-PICI-MS. J Anal Toxicol. 1996;20:362–8.
Choo RE, Murphy CM, Jones HE, Huestis MA. Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, 2-ethyl-5-methyl-3,3-diphenylpyroline and methadol in meconium by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry. J Chromatogr B. 2005;814:369–73.
Shakleya DM, Jansson LM, Huestis MA. Validation of a LC-APCI-MS-MS method for quantification of methadone, 2-ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidine (EDDP) and 2-ethyl-5-methyl-3, 3-diphenylpyroline (EMDP) in infant plasma following protein precipitation. J Chromatogr B. 2007;856:267–72.
Sullivan HR, Due SL. Urinary metabolites of d, l-methadone in maintenance subjects. J Med Chem. 1973;16:909–13.
Verebely K, Volavka J, Salvatore M, Resnick R. Methadone in man: pharmacokinetic and excretion studies in acute and chronic treatment. Clin Pharmacol Ther. 1975;18:180–90.
Henderson GL, Wilson BK, Lau DHM. Plasma l-α-acetylmethadol (LAAM) after acute and chronic administration. Clin Pharmacol Ther. 1977;21:16–25.
Kaiko RF, Inturrisi CE. Disposition of acetylmethadol in relation to pharmacological action. Clin Pharmacol Ther. 1975;18:96–103.
Totah RA, Allen KE, Sheffels P, Whittington D, Kharasch ED. Enantiomeric metabolic interactions and stereoselective human methadone metabolism. J Pharmacol Exp Ther. 2007;321:389–99.
Eap CB, Broly F, Mino A, Hammig R, Uelinger C, Meili D, Chevalley AF, Bertschy G, Zullino G, Kosel M, Preisig M, Baumann P. Cytochrome P450 2D6 genotype and methadone steady-state concentrations. J Clin Psychopharmacol. 2001;21:229–34.
Crettol S, Déglon JJ, Besson J, Croquette-Krokkar M, Gothuey I, Hämmig R, Monnat M, Hüttemann H, Baumann P, Eap CB. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment. Clin Pharmacol Ther. 2005;78:593–604.
Begre S, von Bardeleben U, Ladewig D, Jaquet-Rochat S, Cosendai-Savary L, Golay KP, Kosel M, Baumann P, Eap CB. Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers. J Clin Psychopharmacol. 2002;22:211–5.
Uelinger C, Crettol S, Chasson P, Koeb L, Brawand-Amey M, Eap CB. Increased (R)-methadone plasma concentrations by quetiapine in cytochrome P450s and ABCB1 genotyped patients. J Clin Psychopharmacol. 2007;27:273–8.
Acknowledgements
The authors acknowledge the assistance of Linda Alvarado, Jeffrey Wise and Glenn Schott of the Harris County Medical Examiner’s Office who conducted the LC/MS/MS determinations.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Danielson, T.J., Mozayani, A. & Sanchez, L.A. Methadone and methadone metabolites in postmortem specimens. Forensic Sci Med Pathol 4, 170–174 (2008). https://doi.org/10.1007/s12024-008-9039-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12024-008-9039-7